Saturna Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$761K Sell
17,835
-24,952
-58% -$1.35M 0.01% 99
2026
Q1
$2.68M Sell
42,787
-17
-0% -$1.36K 0.04% 65
2025
Q4
$4.08M Buy
42,804
+583
+1% +$57.2K 0.05% 63
2025
Q3
$4.12M Buy
42,221
+430
+1% +$44.5K 0.05% 67
2025
Q2
$4.49M Buy
41,791
+15,286
+58% +$1.55M 0.06% 63
2025
Q1
$2.67M Buy
26,505
+5
+0% +$503 0.04% 71
2024
Q4
$2.37M Hold
26,500
0.03% 72
2024
Q3
$2.22M Buy
26,500
+400
+2% +$31.5K 0.03% 76
2024
Q2
$2.01M Buy
26,100
+1,250
+5% +$91.5K 0.03% 80
2024
Q1
$1.7M Buy
24,850
+1,250
+5% +$80.4K 0.02% 94
2023
Q4
$1.36M Buy
23,600
+675
+3% +$36K 0.02% 101
2023
Q3
$1.21M Buy
22,925
+925
+4% +$48.5K 0.02% 103
2023
Q2
$1.19M Hold
22,000
0.02% 102
2023
Q1
$1.1M Buy
22,000
+10,000
+83% +$471K 0.02% 102
2022
Q4
$555K Buy
+12,000
New +$520K 0.01% 121

Other funds holding BSX

Saturna Capital's BSX Position: Q2 2026 in Review

Saturna Capital reduced its Boston Scientific (BSX) stake by 58% in Q2 2026, selling an estimated $1.35M and leaving 17,835 shares worth $761K. The position accounts for 0.01% of the portfolio, ranked #99.

Saturna Capital first reported a position in BSX in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.49M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Saturna Capital held 17,835 shares of Boston Scientific worth $761K as of Q2 2026.
  • Saturna Capital sold 24,952 Boston Scientific shares in Q2 2026, an estimated $1.35M.
  • Boston Scientific made up 0.01% of Saturna Capital's portfolio in Q2 2026, its #99 holding.
  • Saturna Capital first reported a position in Boston Scientific in Q4 2022 and has held it in 15 quarters since.
  • Saturna Capital's Boston Scientific position peaked at $4.49M in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Saturna Capital's 13F filing for Q2 2026, filed 14 Aug 2026.